• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

铁过载贫血中的铁吸收：皮下注射去铁胺的效果。

Iron absorption in iron-loading anaemias: Effect of subcutaneous desferrioxamine infusions.

作者信息

Pippard M J, Callender S T, Warner G T, Weatherall D J

出版信息

Lancet. 1977 Oct 8;2(8041):737-9. doi: 10.1016/s0140-6736(77)90238-0.

DOI:10.1016/s0140-6736(77)90238-0
PMID:71542
Abstract

Absorption of 59Fe ferrous sulphate was measured in patients with a variety of iron-loading anaemias both before and during subcutaneous infusions of desferrioxamine. The infusions were associated with a reduction in absorption (P less than 0-025). This effect was not altered by saturation with ascorbic acid.

摘要

在皮下输注去铁胺之前和期间，对患有各种铁负荷贫血的患者测定了硫酸亚铁59Fe的吸收情况。输注与吸收减少有关（P小于0.025）。抗坏血酸饱和并未改变这种效果。

相似文献

1
Iron absorption in iron-loading anaemias: Effect of subcutaneous desferrioxamine infusions.铁过载贫血中的铁吸收：皮下注射去铁胺的效果。
Lancet. 1977 Oct 8;2(8041):737-9. doi: 10.1016/s0140-6736(77)90238-0.
2
Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine.
Lancet. 1977 May 7;1(8019):977-9. doi: 10.1016/s0140-6736(77)92279-6.
3
Iron absorption in non-transfused iron loading anaemias: prediction of risk for iron loading, and response to iron chelation treatment, in beta thalassaemia intermedia and congenital sideroblastic anaemias.
Haematologia (Budap). 1984;17(1):17-24.
4
Improvement in iron status and liver function in patients with transfusional iron overload with long-term subcutaneous desferrioxamine.
Lancet. 1979 May 5;1(8123):947-9. doi: 10.1016/s0140-6736(79)91721-5.
5
Subcutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload.
Lancet. 1976 Dec 11;2(7998):1278-80. doi: 10.1016/s0140-6736(76)92035-3.
6
Intensive iron-chelation therapy with desferrioxamine in iron-loading anaemias.去铁胺强化铁螯合疗法治疗铁过载性贫血。
Clin Sci Mol Med. 1978 Jan;54(1):99-106. doi: 10.1042/cs0540099.
7
Ascorbic acid enhancement of desferrioxamine-induced urinary iron excretion in thalassemia major.
Ann N Y Acad Sci. 1974;232(0):221-5. doi: 10.1111/j.1749-6632.1974.tb20588.x.
8
Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients.
Lancet. 1990 Nov 24;336(8726):1275-9. doi: 10.1016/0140-6736(90)92962-h.
9
Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis.成人输血性血色素沉着症患者持续给予去铁胺的评估。
Trans Assoc Am Physicians. 1977;90:335-41.
10
Iron status in thalassemia major patients after long-term subcutaneous desferrioxamine.长期皮下注射去铁胺后重型地中海贫血患者的铁状态
Birth Defects Orig Artic Ser. 1988;23(5B):111-6.

引用本文的文献

1
Drug Selection and Posology, Optimal Therapies and Risk/Benefit Assessment in Medicine: The Paradigm of Iron-Chelating Drugs.药物选择和剂量、医学中的最佳治疗和风险/效益评估：铁螯合剂药物的范例。
Int J Mol Sci. 2023 Nov 25;24(23):16749. doi: 10.3390/ijms242316749.
2
Intersection of Iron and Copper Metabolism in the Mammalian Intestine and Liver.铁与铜代谢在哺乳动物肠道和肝脏中的交汇。
Compr Physiol. 2018 Sep 14;8(4):1433-1461. doi: 10.1002/cphy.c170045.
3
Tinnitus in a patient with beta-thalassaemia intermedia on long-term treatment with desferrioxamine.
一名中间型β地中海贫血患者长期接受去铁胺治疗后出现耳鸣。
Postgrad Med J. 1981 Sep;57(671):582-4. doi: 10.1136/pgmj.57.671.582.
4
Iron overload: pathogenesis and treatment with chelating agents.
Blut. 1983 Aug;47(2):61-7. doi: 10.1007/BF02482639.
5
Gallium-67 scintigraphy in patients with hemochromatosis treated by deferoxamine.去铁胺治疗的血色素沉着症患者的镓-67闪烁扫描术
Ann Nucl Med. 1988 May;2(1):35-9. doi: 10.1007/BF03164584.